, Reem Atout1, Nader Hamdan2 and Ioannis Tsourounakis3
4.1 Introduction
4.2 Etiology
Bacterial biofilms have been proven to be the primary etiological factor for the initiation of the inflammatory lesion of the periodontal tissues. Several animal studies have demonstrated the mechanisms of the development of the inflammatory lesion around dental implants [2, 3]. Evidence supports that the initiation and progression of peri-implantitis follows the same series of events as periodontal disease.
Etiological factors associated with the prevalence and progression of peri-implantitis
History of periodontal disease |
History of smoking |
Poor oral hygiene |
Diabetes |
Genetic factors—IL-1 polymorphism |
Alcohol consumption |
Implant surface |
Occlusal overload |
Presence of keratinized tissue |
Iatrogenic factors |
4.2.1 History of Periodontal Disease
In a systematic review by Van der Weijden [7], it was concluded that implant survival rates and peri-implant bone loss, of dental implants placed in individuals with a history of treated periodontal disease, might be different from those in periodontally healthy individuals, in the long-term. In another meta-analysis [8], it was also concluded that dental implants placed in patients with a history of treated periodontitis exhibited a higher incidence of peri-implantitis and marginal peri-implant bone loss.
Karoussis et al. [9] evaluated the short- (<5 years) and long-term (>5 years) survival and success rates of dental implants placed in patients with a history of periodontitis. This review demonstrated that implants placed in patients with previously treated periodontal disease have similar survival rates with implants placed in periodontally healthy patients. However, individuals with a history of periodontal disease experienced a significantly higher incidence of peri-implantitis, deeper probing depths, and increased peri-implant bone loss. Late implant loss and peri-implant bone loss was also demonstrated in another systematic review by Quirynen et al. [10]. This was true, especially for implants with a very rough surface, and for patients that were not on a regular maintenance schedule. The rate of late implant loss was three times higher for subjects that did not receive regular maintenance therapy.
Klokkevold and Han [11] concluded that there is no significant difference on survival rates of implants placed in patients with a history of treated periodontitis (95%) compared to patients with no previous history of periodontal disease (97.1%). However, this study indicated that patients with a history of treated periodontal disease experienced significantly lower implant success rates (11.05% better for periodontally healthy patients), as defined by adverse outcomes of peri-implant tissues.
More recently two systematic reviews assessed the survival and success of implants placed in patients with a history of periodontal disease. Zangrando et al. [12] analyzed, the long-term (>5 years) survival and success rates of dental implants placed in patients with a history of periodontal disease. The authors concluded that dental implant therapy can be successful in patients with a history of periodontal disease, as long as the periodontal disease had been properly treated, and the patients were enrolled in a regular maintenance program. The study demonstrated an implant survival rate of 92.1% after 10 years of follow-up. However, increased prevalence of bleeding on probing and residual pocket depths were directly associated with occurrence of peri-implantitis. Furthermore, non-compliance with periodontal maintenance and tobacco smoking had a negative influence on implant outcomes. Another systematic review, reported that implants placed in patients with a history of treated periodontitis had a higher incidence of biological complications and implant loss [13]. Moreover, smoking and lack of periodontal maintenance negatively affected the success of dental implants. Evidence from this review suggested that patients with sites of persistent periodontitis were four times more likely to develop biological complications compared to successfully treated individuals. Moreover, when aggressive periodontitis subjects are treated with implants, a trend for lower implant survival and success rates was noted, when compared to chronic periodontitis individuals or healthy individuals.
A recent study systematically assessed the literature to identify the effect of a history of aggressive periodontitis on implant therapy [14]. The results of this review indicated that the effect of aggressive periodontitis depends on the “end outcome” reported. No significant difference was found when “implant survival” was used as the end outcome, for patients with aggressive periodontitis compared to healthy or chronic periodontitis patients. However, when “implant failure” was considered as the end outcome, a risk ratio for implant loss of 4.00 and 3.97 was identified, when comparing the aggressive periodontitis group with the healthy and the chronic periodontitis groups, respectively. The authors concluded that due to the small sample of failed implants in aggressive periodontitis patients, these numbers should be interpreted with great caution. This review also demonstrated that implants in patients with a history of aggressive periodontitis experienced more marginal bone loss, compared to implants in patients with a history of chronic periodontitis (0.28 mm vs. 0.43 mm). The authors advised caution in the interpretation of this fact, as it might not be clinically significant.
The survival rates of supra-structures and implants are high in individuals with a history of periodontitis-associated tooth loss. However, the higher incidence of peri-implantitis may jeopardize the longevity of the implant treatment. Therefore, implant treatment in periodontitis-susceptible patients is not contraindicated, provided that there is adequate plaque control and that an individualized maintenance program is implemented [15].
4.2.2 Smoking
Cigarette smoking should be considered a risk factor for the long-term survival and maintenance of dental implants. In a systematic review and meta-analysis [16], it was shown that smoking may significantly affect the survival of dental implants, with an implant-related and patient-related OR of 2.25 and 2.69, respectively, when smokers were compared to non-smokers. Previously augmented implant sites showed a significantly higher risk for implant failure when smokers (OR 3.61) were compared to non-smokers (OR 2.15). Furthermore, biological complications, such as peri-implant tissue inflammation and marginal peri-implant bone loss, were found to occur with higher frequency in smoking compared to non-smoking individuals.
In contrast, studies reporting on implants with recently introduced micro-roughened surfaces show a significantly lower risk of implant failure in smokers with an OR of 1.49 [17, 18]. Thus, implant surface treatment may play a role in the survival of implant fixtures in smokers. Smoking was found to have a negative influence on the occurrence of biologic complications on machined, Titanium Plasma Sprayed (TPS) and Hydroxy-apatite (HA) coated implants [19]. However, when comparing implants with particle-blasted and acid-etched (SLA), anodized (TiUnite) and dual acid-etched (Osseotite) surfaces no significant influence of smoking on marginal bone loss was noted around those implants [20].
Patients undergoing implant treatment should be thoroughly informed regarding the potentially negative influence of cigarette smoking on dental implants and their overall health. The positive influence of the newer micro-roughened surfaces on implant survival and peri-implant marginal bone levels should be further investigated, with more studies, and further reinforced with more adequately powered, long-term evidence in large sample sizes.
4.2.3 Poor Oral Hygiene/Lack of Maintenance
Lack of regular peri-implant maintenance care has also been associated with an increased incidence of marginal peri-implant bone loss.
4.2.4 Diabetes, Alcohol Consumption, and Genetic Factors IL-1 Polymorphisms
There is limited evidence to suggest that diabetes, alcohol consumption, or gene polymorphisms can negatively affect peri-implant tissue health and lead to peri-implant bone loss. Although diabetic subjects may be at increased risk for dental implant failure [23], only one study has shown that patients with poor metabolic control may be at increased risk of peri-implantitis [21]. Similarly, there is only one study indicating that individuals consuming >10 g of alcohol daily, may be at increased risk of peri-implant bone loss.
A systematic review by Huyhn-Ba et al. [24] could not reach a conclusion on whether or not IL-1 genotype status is associated with peri-implantitis. The identification of IL-1 gene polymorphisms as risk factors for peri-implant disease cannot be justified at this time.
4.2.5 Dental Implant Surface
The dental implant surface quality may determine the tissue reactions to the implant fixture [25]. Dental implant surface characteristics, such as roughness and chemical treatment, have been shown to play a role in the progression of peri-implant bone loss. The initial Branemark implant carried a machined surface with a roughness (Sa) of 0.5–1.0 μm, and is the most widely researched implant. Rough-surface implants (Sa >2.0 μm TPS and HA coated) were shown to have a favorable bone response which led to faster osseointegration. However, rough-surface implants demonstrated a higher incidence of peri-implantitis and a more rapid progression of marginal bone loss. On the other hand, moderately rough-surface implants (Sa 1.0–2.0 μm most of the implants used today, TiO Blast, SLA, TiUnite, Frialit-2) have shown no increase in the incidence of peri-implantitis and maintenance of the marginal bone levels for a follow-up of 5 years [26]. Nevertheless, in an animal study by Berglundh et al. [27], it was shown that the progression of peri-implantitis, in moderately rough-surface implants (SLA surface), was more pronounced than in smooth-surface implants, if left untreated. In another comparative animal study, it was shown that progression of experimentally induced peri-implantitis occurred in implants with different geometry and surface treatment [28]. Peri-implant marginal bone loss was more pronounced on implants with an anodized surface (TiUnite). In a randomized controlled clinical trial by Wenstromm et al. [29], patients were treated with implant-supported fixed partial dentures and followed up for a period of 5 years. This study demonstrated that implants with a moderately rough surface (TiO Blast Sa 1,5 μ) had similar marginal bone levels with machined surface implants after 5 years in function. In the same study, moderately rough-surface implants demonstrated a similar response to peri-implant bone loss, when compared to implants with a machined surface.
4.2.6 Occlusal Overload
Effect of occlusal overload on peri-implant parameters
48 implants |
Probing depths (mm) |
Bone loss Shoulder crest (mm) |
Bone to implant contact (%) |
---|---|---|---|
Not loaded |
2.5 ± 0.3 |
3.6 ± 0.4 |
73 |
Overloaded |
2.6 ± 0.3 |
3.7 ± 0.2 |
75 |
4.2.7 Lack of Keratinized Tissue
The amount of keratinized mucosa (KM) around dental implants has been discussed in the literature with great controversy. Evidence suggests that KM may not be necessary to maintain peri-implant health [35] and may not be associated with peri-implant bone loss [36]. However, despite its presence, peri-implantitis may still occur [37]. Earlier studies had failed to show any correlation between keratinized and attached mucosal width, and increased implant success [35]. Soft tissue grafting increased the width of keratinized tissue: however, no improvement in implant success rates was noted [38].
4.2.8 Iatrogenic Factors
4.3 Diagnosis
Peri-implantitis is defined as an inflammatory process around a dental implant, which includes both soft tissue inflammation and loss of supporting bone [48, 49]. Due to the similarities, in the pathogenesis, of periodontitis with peri-implantitis, similar criteria have to be used in order to diagnose peri-implantitis [50].
4.3.1 Bleeding on Probing
4.3.2 Probing Depths and Radiographic Evaluation
Clinical assessment of peri-implant tissue health is imperative in order to establish the long-term success of implant treatment. Probing of the peri-implant tissue (25 N probing force) is a safe diagnostic means to identify any deviation from peri-implant tissue health. Any disruption of the soft tissue attachment with the implant surface, by a periodontal probe, will be restored fully by 5 days [53]. Lang et al. [54] have demonstrated that the peri-implant mucosa has the capacity to provide the underlying bone with an excellent seal in the presence of peri-implant mucosal health and peri-implant mucositis. In the presence of peri-implantitis, however, the probe tip will penetrate further to the underlying bone. Hence, probing around dental implants is a valuable tool to monitor peri-implant tissue health and diagnose peri-implant diseases.
Multiple studies have suggested a specific probing depth threshold that can be associated with peri-implant tissue health. However, it is important to note that a sub-crestal position of the implant may often be necessary in order to achieve an optimal outcome, especially in the esthetic zone. This will ultimately result in deeper probing depths, which alone are not considered a sign of peri-implant disease. Thus, it is important to establish a health-related baseline at the time of the connection of the prosthetic components. Comparison of future measurements to baseline is essential to identify the presence of health or pathology [43].
Establishing a baseline is also critical for the radiographic records in order to detect any future bone loss around the implant fixture. Baseline radiographs should be taken at implant placement and after the connection of the restorative component [43], as bone loss prior to this time point may be due to iatrogenic factors or normal bone turnover during the healing phase. Every effort should be made to standardize these radiographs by taking them perpendicular to the implant body, with a clear demarcation of the restorative platform and the implant threads. The implant threads will serve as points of reference to diagnose peri-implant bone loss in future radiographs.